The Raymond Poincaré University Hospital is a hospital of the Assistance publique - Hôpitaux de Paris and a teaching hospital of Versailles Saint-Quentin-en-Yvelines University. Located at Garches, it was built between 1932 and 1936 and named after Raymond Poincaré, French president from 1913 to 1920.

There are 386 beds in Hopital Raymond Poincare.

During the past decade, Hopital Raymond Poincare conducted 97 clinical trials. In the 10-year time frame, 97 clinical trials started and 14 clinical trials were completed, i.e. on average, 14.4% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 4 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Raymond Poincare" #1 sponsor was "Centre d'Investigation Clinique et Technologique 805" with 55 trials, followed by "Assistance Publique - Hôpitaux de Paris" with 19 trials sponsored, "University of Versailles" with 10 trials sponsored, "Ipsen" with 7 trials sponsored and "ANRS, Emerging Infectious Diseases" with 7 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Raymond Poincare" #1 collaborator was "Assistance Publique - Hôpitaux de Paris" with 9 trials as a collaborator, "Fondation Garches" with 8 trials as a collaborator, "Adep Assistance" with 5 trials as a collaborator, "Association Française contre les Myopathies (AFM), Paris" with 4 trials as a collaborator and "Hôpital Raymond Poincaré" with 4 trials as a collaborator. Other collaborators include 97 different institutions and companies that were collaborators in the rest 94 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Raymond Poincare" are "Neuromuscular Disease" (7 trials), "HIV Infections" (6 trials), "Respiratory Failure" (6 trials), "Critical Illness" (5 trials) and "Neuromuscular Diseases" (5 trials). Many other conditions were trialed in "Hopital Raymond Poincare" in a lesser frequency.

Most popular intervention types in "Hopital Raymond Poincare" are "Drug" (49 trials), "Other" (44 trials), "Device" (31 trials), "Procedure" (12 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Botulinum toxin type A" (6 trials), "AT2221" (2 trials), "ATB200" (2 trials) and "Hyperbaric oxygen therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Raymond Poincare" are 157 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hopital Raymond Poincare". 1 are not yet recruiting, 16 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 102 completed trials in Hopital Raymond Poincare, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Raymond Poincare, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 59 trials that are defined as “Not Applicable".